The drug, a deadly combo of an antibody glued to an antibiotic, specifically seeks and destroys Staphylococcus aureus—even the difficult-to-kill, drug-resistant variety, methicillin-resistant staph (MRSA). In mice infected with MRSA, the dynamic duo fought off the infection better than the standard antibiotic treatment of vancomycin, researchers report in Nature. If the findings hold true in humans, the new superdrug could vastly improve the success rate of MRSA infection treatments, which currently fail about 50 percent of the time...
Thursday, November 05, 2015
Fighting Superbugs
"Antibody-antibiotic superdrug triumphs over MRSA superbug in mice":